# FDA Inspection 787415 - Novartis Pharma S.A.S. - Centre de Biotechnologie - January 31, 2012

Source: https://www.keypedia.com/records/fda_inspections/novartis-pharma-sas-centre-de-biotechnologie/3c706dab-e80c-432f-92f8-86014a86b91c
Source feed: FDA_Inspections

> FDA Inspection 787415 for Novartis Pharma S.A.S. - Centre de Biotechnologie on January 31, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 787415
- Company Name: Novartis Pharma S.A.S. - Centre de Biotechnologie
- Inspection Date: 2012-01-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1173120 - 2020-11-19](https://www.keypedia.com/records/fda_inspections/novartis-pharma-sas-centre-de-biotechnologie/226afa98-03a6-469d-918c-394a0de046c8)
- [FDA Inspection 1026805 - 2017-09-12](https://www.keypedia.com/records/fda_inspections/novartis-pharma-sas-centre-de-biotechnologie/8615aa30-3785-4cab-af8d-bbcb1a2be973)
- [FDA Inspection 878418 - 2014-03-18](https://www.keypedia.com/records/fda_inspections/novartis-pharma-sas-centre-de-biotechnologie/93860947-3a74-4239-91f5-e7a616475eac)

Company: https://www.keypedia.com/companies/novartis-pharma-sas-centre-de-biotechnologie/af3b3928-8e26-49ec-b7d4-865a757d3a53

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c